ARCHIVES

ODAC Recommends Ethyol, DaunoXome For FDA Approval

This article is from The Cancer Letter archive.

Vol. 21 No. 24 | June 16, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

Henschke and Supporters Call For Urgent Action Based On Results Of NLST

May 13, 2011

Harkin, Hatfield Propose Trust Fund to Raise Research Funding

May 28, 1993

NCI Appropriations, Authorization Bills Passed By House

September 5, 1980